SHANGHAI and WEST PALM BEACH, Fla., Jan. 7, 2018 /PRNewswire/ — F1 Oncology, Inc., a biotechnology company discovering and developing adoptive cellular therapies (ACTs) for solid tumors, today announced receipt of a $10 million equity investment from its current investors upon ethics…
